Parameters | Group | N | Mean ± S.D. | P value |
---|---|---|---|---|
HSP70 (ng/ml) | Control | 8 | 10.563 ± 0.370 | |
PA | 8 | 9.400 ± 0.490 | 0.001a | |
CoQ-Protected group | 6 | 10.050 ± 0.404 | 0.030a | |
CoQ-treated group | 8 | 10.033 ± 0.427 | 0.029a | |
GABA (ng/10 mg) | Control | 8 | 109.100 ± 4.666 | |
PA | 8 | 67.183 ± 3.125 | 0.001a | |
CoQ-Protected group | 6 | 95.417 ± 4.529 | 0.01a | |
CoQ-treated group | 8 | 85.079 ± 4.832 | 0.01a | |
Serotonin (ng/ml) | Control | 8 | 0.073 ± 0.017 | |
PA | 8 | 0.047 ± 0.011 | 0.004a | |
CoQ-Protected group | 6 | 0.095 ± 0.018 | 0.043a | |
CoQ-treated group | 8 | 0.097 ± 0.018 | 0.033a | |
Dopamine (ng/ml) | Control | 8 | 136.250 ± 18.468 | |
PA | 8 | 106.875 ± 12.229 | 0.002a | |
CoQ-Protected group | 6 | 169.167 ± 24.580 | 0.014a | |
CoQ-treated group | 8 | 160.000 ± 22.583 | 0.051a | |
Oxytocin (Pg/ml) | Control | 8 | 89.750 ± 4.464 | |
PA | 8 | 84.500 ± 4.751 | 0.039a | |
CoQ-Protected group | 6 | 95.667 ± 4.967 | 0.037a | |
CoQ-treated group | 8 | 95.000 ± 3.742 | 0.038a | |
Interferon μ inducible protein 16 (Pg/ml) | Control | 8 | 833.750 ± 63.906 | |
PA | 8 | 768.750 ± 53.033 | 0.044a | |
CoQ-Protected group | 6 | 931.667 ± 77.567 | 0.024a | |
CoQ-treated group | 8 | 983.333 ± 60.222 | 0.001a |